6 12, 2023

Considerations for the use of high-purity recombinant growth factors in cellular agriculture applications

2024-01-05T13:37:53+00:00December 6th, 2023|Blog, cellular agriculture|

Cultivated meat is a nascent industry with a developing regulatory framework, with distinct regional differences. There are however some shared themes across regulatory frameworks and best practice. Within the UK and EU, cultivated meat is considered a novel food and as such falls under the scope of Regulation (EU) No. 2015/2283. In response to this classification, the Food Safety Agency commissioned an internal report into the potential hazards to the consumer associated with the production and consumption of cultured meat. Following a literature review of 154 papers discussing cultured meat as a technology, themes that apply to growth factors have been highlighted and discussed.

8 09, 2023

Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production

2023-09-08T10:14:19+00:00September 8th, 2023|cellular agriculture, News, Press Release|

Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production

21 07, 2023

My first ISSCR – sharing is power – Sveva Bottini shares her experience of ISSCR 2023

2023-07-21T09:58:18+00:00July 21st, 2023|Blog, cellular agriculture, Event|

In this personal blog piece, Sveva Bottini from the Bertero Lab in Turin, shares her experiences of ISSCR 2023 in Boston. During the event, Qkine was proud to co-sponsor a poster abstract by Sveva on ‘Optimization of growth factors for human pluripotent stem cell culture in basal 8 media.’

22 02, 2023

Protein origami to change the future of food

2023-02-22T14:25:34+00:00February 22nd, 2023|Blog, cellular agriculture|

Are you looking for an idea to start a multimillion-pound business? Proteins that stimulate cell growth currently cost several million pounds per gram, which makes them more expensive than diamonds. You need particularly lots of them if you want to grow enough cells to assemble a steak. This so-called ‘cultivated’ or ‘lab-grown’ meat was initially proposed as food for astronauts but has since turned from a science fiction fantasy to a source of hope for a more sustainable and animal welfare-conscious food for the world.

23 11, 2022

Qkine and 3D Bio-Tissues collaboration awarded €100,000 at EIT Food Venture Summit 2022

2022-11-23T06:46:58+00:00November 23rd, 2022|Awards, cellular agriculture, News, Press Release|

A collaboration between Qkine and 3D Bio-Tissues has been awarded one of four prestigious prizes at the 2022 EIT Food Venture Summit, held in Lisbon, Portugal. Prize money will be used to develop new solutions to reduce the cost of cultivated meat.

10 01, 2022

the 5th anniversary of Qkine

2022-01-10T09:30:43+00:00January 10th, 2022|cellular agriculture, News, protein science, Resources, stem cells|

There has been an impressive drive towards innovation in stem cell protocols this year. As 2021 comes to a close, we reflect on the highlights for stem cell science over the year. It was great to see new culture media, such as B8 and “Beefy-9”, published, developments in cultivated meat science hit the news and iPSC-based therapies edge closer to the clinic. Reproducibility remains the underlying theme, and indeed requirement, for maximising the impact of these wonderful developments and at Qkine we’ll continue to do everything we can to help in 2022.

10 09, 2021

Qkine earns ISO9001: 2015 certification for protein R&D and manufacture facilities in Cambridge, UK

2021-09-10T18:53:50+00:00September 10th, 2021|Awards, cellular agriculture, News, Press Release, quality|

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.

26 07, 2021

Qkine and Enantis sign licensing deal for hyperstable FGF2-STAB®

2021-07-26T08:14:57+00:00July 26th, 2021|animal-free, cellular agriculture, News, Press Release, protein engineering, protein science, stem cells|

Qkine and Enantis have concluded a global licensing deal for Enantis’s patented FGF2-STAB® technology. FGF2-STAB® is a hyperstable form of FGF-2 (bFGF), a core reagent for stem cell culture. FGF2-STAB (FGF2-G3) does not degrade in culture media for enhanced weekend-free stem cell culture media and advanced chemically defined systems, such as those needed in the cultured meat industry.


Go to Top